UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000017742
Receipt No. R000020554
Scientific Title Analysis of expression of CD44 and podocalyxin in head and neck cancer
Date of disclosure of the study information 2015/06/01
Last modified on 2018/10/14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Analysis of expression of CD44 and podocalyxin in head and neck cancer
Acronym Analysis of expression of CD44 and podocalyxin in head and neck cancer
Scientific Title Analysis of expression of CD44 and podocalyxin in head and neck cancer
Scientific Title:Acronym Analysis of expression of CD44 and podocalyxin in head and neck cancer
Region
Japan

Condition
Condition head and neck cancer
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Analysis of expression of CD44 and podocalyxin in head and neck cancer
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Expression of CD44 and podocalyxin in head and neck cancer
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Head and neck cancer
Key exclusion criteria patient who reject joining in this trial
Target sample size 50

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Eiji Yumoto
Organization Kumamoto University Graduate School of Medicine
Division name Department of Otolaryngology-Head and Neck Surgery
Zip code
Address 1-1-1 Honjo, Kumamoto 860-8556, Japan
TEL 096-373-5255
Email jibika-ikyoku@fc.kuh.kumamoto-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Daizo Murakami
Organization Kumamoto University Graduate School of Medicine
Division name Department of Otolaryngology-Head and Neck Surgery
Zip code
Address 1-1-1 Honjo, Kumamoto 860-8556, Japan
TEL 096-373-5255
Homepage URL
Email daizo-m@fc.kuh.kumamoto-u.ac.jp

Sponsor
Institute Kumamoto University Graduate School of Medicine
Institute
Department

Funding Source
Organization Grants-in-Aid for Scientific Research
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 熊本大学医学部付属病院

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2012 Year 07 Month 01 Day
Date of IRB
Anticipated trial start date
2012 Year 07 Month 01 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
2016 Year 03 Month 31 Day
Date trial data considered complete
2016 Year 03 Month 31 Day
Date analysis concluded
2016 Year 03 Month 31 Day

Other
Other related information There is no expression op podocalyxin in squamous cell carcinoma of head and Neck. So, this study was finished.

Management information
Registered date
2015 Year 05 Month 30 Day
Last modified on
2018 Year 10 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020554

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.